Table of Contents Table of Contents
Previous Page  2 / 3 Next Page
Information
Show Menu
Previous Page 2 / 3 Next Page
Page Background

Note:

Page 35

April 11-12, 2019 | Barcelona, Spain

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

alliedacademies.com

YEARS

Dermatology 2019

Research in Clinical Dermatology | Volume 2

3

rd

WORLD DERMATOLOGY

AND COSMETOLOGY CONGRESS

GENETIC STUDIES ON PSORIASIS: ROLE OF

METHYLENETETRAHYDROFOLATE

REDUCTASE

(

MTHFR

) C677T GENE POLYMORPHISM

Abdulrahman Al-Asmari

Scientific Research Center, KSA

P

soriasis is a chronic, immune-mediated inflammatory skin disease affecting approximately 120-180 million

people worldwide. The pathogenesis of psoriasis is very complex and several different etiological hypothe-

ses including those of the genetic, environmental and immunological factors have been suggested to explain

its pathogenesis.

Methylenetetrahydrofolate reductase

(

MTHFR

) has been linked with the etiopathogenesis of

psoriasis with inconsistent results. The aim of this study was to determine if the

MTHFR

(C677T) polymorphism

confers susceptibility to psoriasis in Saudi population. We evaluated

MTHFR

C677T polymorphism in 106 Saudi

psoriasis vulgaris patients and 280 matched healthy controls.

MTHFR

C677T genotyping was performed by

PCR–RFLP technique. Allele T and genotypes CT, TT were found to be increased while allele C and genotype

CC significantly decreased in psoriasis patients than controls (p <0.001). This study indicates that the T-allele

and T-containing genotypes (TT, CT) of

MTHFR

C677T polymorphism are significantly associated with psoriasis

while C-allele and CC genotype may be protective for it. BMI, fasting glucose, triglycerides, total cholesterol,

low-density lipoprotein and C-reactive protein, known markers for cardiovascular diseases were found to be

significantly elevated in the patient group as compared to the controls. It is concluded that the

MTHFR

C677T

polymorphism increases psoriasis risk in Saudi patients and ultimately may lead to cardiovascular and other

systemic disorders.

Abdulrahman Al-Asmari, Res Clin Dermatol 2019, Volume 2

Abdulrahman Al-Asmari has completed his PhD in 1996 from University of London, London, UK. Earlier he received MPhil (biochem-

istry) on his work entitled “Proteomic studies of snake venoms and their biological activity” from London, UK. He is the director of

Scientific Research Center, MSD Riyadh Saudi Arabia. He has over 100 publications that have been cited several times, and has been

serving as an editorial board member of various journals.

misbahularfin@yahoo.com

BIOGRAPHY